Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |